Highmark Members Save Significant Money on Outpatient Cancer Drug Available Through CivicaScript
May 31, 2024
May 31, 2024
PITTSBURGH, Pennsylvania, May 31 -- Highmark, a health insurance company, issued the following news release:
Highmark members are saving money on their generic oral oncology medication prescriptions through Highmark's leading role in a nationwide initiative to lower costs and boost access to generic medications.
Highmark members taking abiraterone acetate, which is used to treat prostate cancer, are saving an average of $90 per month in out-of-pocket expenses for the m . . .
Highmark members are saving money on their generic oral oncology medication prescriptions through Highmark's leading role in a nationwide initiative to lower costs and boost access to generic medications.
Highmark members taking abiraterone acetate, which is used to treat prostate cancer, are saving an average of $90 per month in out-of-pocket expenses for the m . . .